We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Consumer Discretionary 15.2%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
226
Emerson Electric
EMR
$82.9B
$544K 0.01%
8,200
-2,575
-24% -$173K
ITW icon
227
Illinois Tool Works
ITW
$81.4B
$411K 0.01%
4,700
– –
MSM icon
228
MSC Industrial Direct
MSM
$7.02B
$315K 0.01%
3,300
-1,900
-37% -$173K
MET icon
229
MetLife
MET
$61B
$222K 0.01%
+4,488
New +$210K
CBSH icon
230
Commerce Bancshares
CBSH
$8.5B
$214K 0.01%
8,286
– –
AXP icon
231
American Express
AXP
$223B
$189K ﹤0.01%
+2,000
New +$180K
HCC
232
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
$176K ﹤0.01%
3,600
– –
HYG icon
233
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$142K ﹤0.01%
1,500
+1,000
+200% +$94.5K
CVX icon
234
Chevron
CVX
$388B
$78K ﹤0.01%
600
– –
JNK icon
235
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
$62K ﹤0.01%
500
+333
+199% +$41.4K
GPC icon
236
Genuine Parts
GPC
$17.1B
$61K ﹤0.01%
700
– –
CVS icon
237
CVS Health
CVS
$137B
$52K ﹤0.01%
692
– –
NNN icon
238
NNN REIT
NNN
$9.39B
$52K ﹤0.01%
1,400
– –
HD icon
239
Home Depot
HD
$332B
$40K ﹤0.01%
500
-150
-23% -$11.8K
JNJ icon
240
Johnson & Johnson
JNJ
$635B
$31K ﹤0.01%
300
– –
INTC icon
241
Intel
INTC
$466B
$30K ﹤0.01%
1,000
– –
KMP
242
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$24K ﹤0.01%
300
– –
BDX icon
243
Becton Dickinson
BDX
$43.1B
$23K ﹤0.01%
205
– –
V icon
244
Visa
V
$677B
$18K ﹤0.01%
348
– –
RHI icon
245
Robert Half
RHI
$3.61B
$11K ﹤0.01%
250
– –
DLR icon
246
Digital Realty Trust
DLR
$73.7B
– –
-149,600
Closed -$7.94M
HCSG icon
247
Healthcare Services Group
HCSG
$1.56B
– –
-280,855
Closed -$8.16M
KSS icon
248
Kohl's
KSS
$2.03B
– –
-300
Closed -$17K
MASI
249
DELISTED
Masimo
MASI
– –
-131,615
Closed -$3.59M
MMM icon
250
3M
MMM
$89B
– –
-179
Closed -$20K
7 8 9
10
11

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.